Biomarkers in Tissue Samples From Patients With Newly Diagnosed Breast Cancer Treated With Zoledronic Acid
Status:
Terminated
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
This pilot clinical trial studies biomarkers in tissue samples from patients with newly
diagnosed breast cancer treated with zoledronic acid (ZA). Studying samples of tumor tissue
in the laboratory from patients receiving ZA may help doctors learn more about the effects of
ZA on cells. It may also help doctors understand how well patients respond to treatment.